Levitra

Wenning said Bayer wants to widen its health-care unit and would consider making acquisitions to expand its over-the-counter drug lineup — providing that targets fit Bayer's business plan.

Wenning made the remark at a news conference when asked whether Bayer would bid for Pfizer's over-the-counter division, if it were put up for sale.

Pfizer said last month it might sell or spin off the unit.

Bayer's crop science division had a slight decline in sales of less than one per cent to 5.89 billion euros ($7.07 billion) while its MaterialScience unit, which produces and sells plastics, reported growth of 24.4 per cent to 10.69 billion euros ($12.8 billion) in 2005.

Shares of Bayer were down nearly 3.8 per cent to 32.52 euros ($39.08) in Frankfurt trading.Get great home delivery subscription deals here!

Previous Story Print Story E-mail Story > Advertisement < FAQs Life Legal Notice: Copyright Toronto Star Newspapers Limited.

All rights reserved.

Distribution, transmission or republication of any material from www.thestar.com is strictly prohibited without the prior written permission of Toronto...

Read more...